Evidence map›Paper›PMID 11024154›Full record

ArticleJournal of virology2000

Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies.

A Singh, R G Collman

Abstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Coreceptor use in nonhuman primate models of HIV infection.Journal of translational medicine · 2011
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A SinghDepartment of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
R G Collman

Funding

Dual-Tropic HIV-1 Strains and Primary Cell InfectionR01AI035502 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 1998 to 2009
$2.9M
HIV ACTIVATION &REGULATION IN LUNG--VIRAL DETERMINANTSR01HL058004 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 1996 to 2000
$278k
HIV-1 VPR IN INFECTION OF PRIMARY MACROPHAGESR29AI035502 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI COLLMAN, RONALD G · 1994 to 1997
–
NHLBI NIH HHS HL 58004NIAID NIH HHS AI 35502NIAID NIH HHS R01 AI035502
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) variants that use the coreceptor CCR5 for entry (R5; macrophage tropic) predominate in early infection, while variants that use CXCR4 emerge during disease progression. Some late-stage variants use CXCR4 alone (X4; T-cell tropic), while others use both CXCR4 and CCR5 (R5X4; dualtropic). It has been proposed that dualtropic R5X4 strains are intermediates in the evolution from R5 to X4, and we hypothesized that a dualtropic primary-isolate quasispecies might contain variants that represent the spectrum of coreceptor use in vivo. We generated a panel of 35 functional full-length env clones from the primary-isolate quasispecies of a dualtropic prototype strain, HIV-1 89.6(PI). Thirty of the functional env clones (86%) were R5X4, four (11%) were R5, and one (3%) was predominantly X4. V3 to V5 sequences did not reveal clustering by coreceptor usage, and no specific sequence motif or V3 charge pattern corresponded to coreceptor utilization. Complete sequencing of seven functionally divergent Env proteins revealed > or =98.7% homology and conservation of structurally important domains. Chimeras between the R5X4 89.6 prototype and an R5 variant indicated that multiple regions contributed to the use of CXCR4, while chimeras with the X4 variant implicated a single residue in V4 in CCR5 use. These results confirm, at the molecular level, both that dualtropic variants are a predominant component of late-stage syncytium-inducing isolates and that variants restricted to each coreceptor coexist with dualtropic species in vivo. Coreceptor-restricted minority variants may reflect residual R5 species from earlier in disease as well as emerging X4 variants.

Indexed as

Genetic VariationAmino Acid SequenceCloning, MolecularGene Products, envHIV-1HIV Envelope Protein gp120HumansMolecular Sequence DataPeptide FragmentsPhylogenyPolymerase Chain ReactionReceptors, CCR5Receptors, CXCR4Recombinant Fusion ProteinsSequence AlignmentVirionGene Products, envHIV Envelope Protein gp120HIV envelope protein gp120 (305-321)Peptide FragmentsReceptors, CCR5Receptors, CXCR4Recombinant Fusion Proteins

Identifiers

PMID11024154
PMCPMC102064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.